PT932400E - Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica - Google Patents

Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica

Info

Publication number
PT932400E
PT932400E PT97932615T PT97932615T PT932400E PT 932400 E PT932400 E PT 932400E PT 97932615 T PT97932615 T PT 97932615T PT 97932615 T PT97932615 T PT 97932615T PT 932400 E PT932400 E PT 932400E
Authority
PT
Portugal
Prior art keywords
anticonvulsioners
derivatives
treatment
neuropatic pain
neuropatic
Prior art date
Application number
PT97932615T
Other languages
English (en)
Inventor
Richard P Shank
Kenneth Wild
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of PT932400E publication Critical patent/PT932400E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97932615T 1996-10-08 1997-07-16 Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica PT932400E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2768796P 1996-10-08 1996-10-08

Publications (1)

Publication Number Publication Date
PT932400E true PT932400E (pt) 2003-03-31

Family

ID=21839205

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97932615T PT932400E (pt) 1996-10-08 1997-07-16 Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica

Country Status (23)

Country Link
EP (1) EP0932400B1 (pt)
JP (1) JP4097294B2 (pt)
KR (1) KR100496934B1 (pt)
CN (1) CN1105559C (pt)
AP (1) AP1513A (pt)
AT (1) ATE226071T1 (pt)
AU (1) AU725570B2 (pt)
BR (1) BR9712503A (pt)
CA (1) CA2267945C (pt)
CZ (1) CZ296525B6 (pt)
DE (1) DE69716453T2 (pt)
DK (1) DK0932400T3 (pt)
ES (1) ES2187795T3 (pt)
HU (1) HU225031B1 (pt)
IL (1) IL129276A (pt)
NO (1) NO321390B1 (pt)
NZ (1) NZ334981A (pt)
PT (1) PT932400E (pt)
RU (1) RU2175868C2 (pt)
SI (1) SI0932400T1 (pt)
SK (1) SK284271B6 (pt)
UA (1) UA48256C2 (pt)
WO (1) WO1998015270A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100653326B1 (ko) * 1999-01-19 2006-12-04 오르토-맥네일 파마슈티칼, 인코퍼레이티드 클러스터 두통을 치료하는데 유용한 진경제 유도체
AU3582600A (en) * 1999-01-21 2000-08-07 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating transformed migraine
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
TW200812573A (en) 2006-05-19 2008-03-16 Janssen Pharmaceutica Nv Co-therapy for the treatment of epilepsy and related disorders
JP5912269B2 (ja) 2011-03-11 2016-04-27 ローランド株式会社 電子楽器
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine

Also Published As

Publication number Publication date
DE69716453T2 (de) 2003-02-27
NO991621D0 (no) 1999-04-06
BR9712503A (pt) 1999-10-19
ES2187795T3 (es) 2003-06-16
WO1998015270A1 (en) 1998-04-16
HUP9904294A3 (en) 2001-08-28
CN1232393A (zh) 1999-10-20
IL129276A (en) 2003-04-10
DE69716453D1 (de) 2002-11-21
AU3602297A (en) 1998-05-05
UA48256C2 (uk) 2002-08-15
CA2267945A1 (en) 1998-04-16
NZ334981A (en) 2000-08-25
NO321390B1 (no) 2006-05-08
IL129276A0 (en) 2000-02-17
AP9901508A0 (en) 1999-06-30
SI0932400T1 (en) 2002-12-31
AU725570B2 (en) 2000-10-12
CZ296525B6 (cs) 2006-04-12
EP0932400A1 (en) 1999-08-04
CZ115799A3 (cs) 1999-09-15
HU225031B1 (en) 2006-05-29
HUP9904294A2 (hu) 2001-04-28
ATE226071T1 (de) 2002-11-15
SK284271B6 (sk) 2004-12-01
DK0932400T3 (da) 2003-02-10
NO991621L (no) 1999-05-25
KR20000048871A (ko) 2000-07-25
EP0932400B1 (en) 2002-10-16
CN1105559C (zh) 2003-04-16
SK45499A3 (en) 2000-08-14
AP1513A (en) 2005-12-12
JP4097294B2 (ja) 2008-06-11
KR100496934B1 (ko) 2005-06-23
JP2001501643A (ja) 2001-02-06
RU2175868C2 (ru) 2001-11-20
CA2267945C (en) 2005-05-17

Similar Documents

Publication Publication Date Title
DE69630947D1 (de) Mittel zur schmerzbehandlung
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
EE03512B1 (et) Epinastiin kasutamiseks valude ravis
NO984431D0 (no) FremgangsmÕte for behandling av smerte
NO983266D0 (no) Distribuert Behandling
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DE69825447D1 (de) Gerät zur dermatologischen behandlung
DE69718990D1 (de) Behandlungsgerät
DE69623722T2 (de) Blutbehandlungsgerät
DE69704612D1 (de) Dentalmasse und dental-produkt
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
DE69524138T2 (de) Hautbehandlungsmittel
FI972919A0 (fi) Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa
DE59609662D1 (de) Haarbehandlungsmittel
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69732024D1 (de) Haarbehandlungsmittel
NO984446D0 (no) FremgangsmÕte for behandling av smerte
NO983263D0 (no) Distribuert behandling
PT1089965E (pt) Derivados de ureia para tratamento da dor
DE59708501D1 (de) Haarbehandlungsmittel
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO982562D0 (no) Sammensetning for behandling av smerte
BR9610382A (pt) Composição de tratamento do cableo
DE29612101U1 (de) Behandlungsliege